Urinary exosome-derived miRNA gene biomarkers for diagnosis of antibody-mediated rejection in kidney allografts and use thereof

摘要

The present invention relates to a urine exosome-derived miRNA gene biomarker and its use for diagnosis of antibody-mediated rejection after kidney transplantation, and more particularly, antibody-mediated rejection (ABMR) after kidney transplantation. It relates to a biomarker, a composition for diagnosing an antibody-mediated rejection reaction, a kit, a method for providing information for diagnosis of an antibody-mediated rejection reaction using the same, and a screening method for an antibody-mediated rejection treatment agent.